Merck & Co Inc <MRK.N>: Argus Research raises target price to $170 from $145
MRK•Related News
McKesson agrees to buy Precision Medicine Group for $2.25 billion
MCK•
Nuwellis enters co-promotion, distribution pact with Atrility for AtriAmp device
NUWE•
Moody’s integrates credit ratings, research into Google Cloud’s Gemini Enterprise for Financial Services
MCO•
Polaryx Therapeutics targets Q4 2026 start for SOTERIA Phase 2 PLX-200 basket trial
PLYX•
Springbig targets strategic transactions for private firms valued at $10 million-$50 million
SBIG•